Bliss GVS Pharma Limited (BLISSGVS.BO)
- Previous Close
116.75 - Open
118.95 - Bid 122.30 x --
- Ask 123.25 x --
- Day's Range
117.05 - 125.20 - 52 Week Range
71.00 - 148.95 - Volume
68,933 - Avg. Volume
65,629 - Market Cap (intraday)
12.835B - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
14.77 - EPS (TTM)
8.30 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield 0.50 (0.41%)
- Ex-Dividend Date Jul 12, 2023
- 1y Target Est
170.00
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
www.blissgvs.com763
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: BLISSGVS.BO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BLISSGVS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BLISSGVS.BO
Valuation Measures
Market Cap
12.84B
Enterprise Value
12.12B
Trailing P/E
14.77
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.78
Price/Book (mrq)
1.38
Enterprise Value/Revenue
1.61
Enterprise Value/EBITDA
8.22
Financial Highlights
Profitability and Income Statement
Profit Margin
11.62%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
7.57B
Net Income Avi to Common (ttm)
879.46M
Diluted EPS (ttm)
8.30
Balance Sheet and Cash Flow
Total Cash (mrq)
1.63B
Total Debt/Equity (mrq)
10.34%
Levered Free Cash Flow (ttm)
--
Research Analysis: BLISSGVS.BO
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: BLISSGVS.BO
BLISSGVS.BO does not have Company Insights